Purity: | 99% | Mf: | C16h15f6n5o |
---|---|---|---|
Cas No.: | 486460-32-6 | Einecs No.: | 690-730-1 |
Appearance: | White Powder | Usage: | Pharmaceutical Intermediates |
Shelf Life: | 24 Month | Test Method: | HPLC |
Melting Point: | 114.1-115.7 °c | ||
High Light: | API Active Pharmaceutical Ingredient,Human API Pharma Ingredients |
Diabetes Treatment API Raw Material Sitagliptin CAS 486460-32-6
Production name | Sitagliptin |
MOQ | 1KG |
CAS No. | 486460-32-6 |
Appearance | White to off white powder |
Molecular Formula | C16H15F6N5O |
Molecular Weight | 407.31 |
Assay | 99% |
Application | Pharma grade |
The Introductction of Sitagliptin :
Sitagliptin is the first novel dipeptidyl peptidase IV inhibitor from Merck for the treatment of type 2 diabetes without weight gain and the incidence of hypoglycemia was similar to placebo. Sitagliptin acts by enhancing the body's incretin system, which helps to regulate glucose by affecting β and α cells in the pancreas.
The Application & Function of Sitagliptin :
Sitagliptin is a useful pharmaceutical drug. Could be useful for treating intestinal inflammation, diabetes, pre-?diabetes, impaired glucose tolerance, hepatitis, and inflammatory liver disease.
The COA of Sitagliptin :
Items | Specifications | Test results |
Appearance | White crystalline powder | Conform |
Solubility | Soluble in water | Conform |
Identification |
IR HPLC RT |
Conform Conform |
Melting point | 202.0~204.0°C | 202.0~203.0°C |
Water (by KF) | ≤1.0% | 0.9% |
Specific rotation | -18 ~ -23.0°(C=1.0 water) | -21.3° |
Residue on ignition | ≤0.1% | 0.01% |
Heavy metals | ≤20ppm | Conform |
Chiral impurity | ≤1.0% | 0.02% |
Related substances | Any single impurity≤0.5% | 0.01% |
Total impurity≤1.0% | 0.05% | |
Assay (by HPLC) | 98.0~102.0% | 99.4% |